Industry News:

Innovaro Pharmalicensing

Latest: Watch here for details of new products and services.

About Us: Innovaro Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Pay-per-Click New!; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Innovaro Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Innovaro Pharmalicensing
is a division of
Innovaro Europe Ltd

Innovaro Corporation

Industry news

Related news

Latest News

REG-ECO Animal Health Group plc, Re Joint Venture

King Pharmaceuticals Announces US Department of Justice Settlement

Physiomics to collaborate with Sareum, the ICR and CRT on cancer drug development programme

Paladin Makes First Step Into Emerging Markets Through Strategic Investment in Pharmaplan

Mylan Announces First-to-File Opportunity Settlement Agreements for Actoplus Met

ERT Offers a New Self-Rated Version of the C-SSRS, Facilitating Prospective Suicidality Monitoring

RANBAXY ANNOUNCES SETTLEMENT OF ACTOS

Vernalis earns milestone payment in Hsp90 inhibitor collaboration

Lilly to Acquire Global License to AXIRON Testosterone Solution From Acrux

Taylor Technology Provides Complete Pharmacokinetic Studies Within Five Days Or Less

More news... | RSS Feed...

Most Viewed

MediGene and Teva sign agreement to commercialize Veregen(TM) in Israel

Regulus Therapeutics and GlaxoSmithKline Establish New Collaboration to Develop and Commercialize microRNA Therapeutics Targeting miR-122

Genoptix Announces National Three-Year Agreement With Aetna

St. Jude Medical Expands Hospital Access to Wireless Fractional Flow Reserve Technology with New Agreement

Cardiff University and Merck Serono Launch International Survey For Couples Trying To Conceive

GTC PROVIDES UPDATE ON TG20 MONOCLONAL ANTIBODY TARGETING CD20

Galapagos delivers third candidate drug in GSK alliance, receives EUR5.7 million

Advanced Cell Technology's RPE Cells Granted Orphan Drug Status from FDA for Treatment of Stargardt's Macular Dystrophy

PALATIN TECHNOLOGIES, INC. TO RAISE $2.6 MILLION DOLLARS IN REGISTERED DIRECT OFFERING

AstraZeneca and Rigel Pharmaceuticals Sign Worldwide License Agreement for Late-Stage Development Product -- Fostamatinib Disodium (R788) -- for the Treatment of Rheumatoid Arthritis

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Innovaro Pharmalicensing current industry press releases.

Products:	Partnering Search	Pay-per-Click	Company Profiling	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us

© Copyright 1998-2010 Innovaro Pharmalicensing, a division of Innovaro Europe Ltd All rights reserved. Terms and Conditions | Contact us